Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma

Background: Some researchers have suggested that vitamin K enhances the antitumor effect of sorafenib for hepatocellular carcinoma (HCC) in vitro and in vivo. In this study, we examined the clinical impact of vitamin K dosing for sorafenib treatment. Methods: Twenty-nine out of 65 patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Haruna, Yoshimichi, Hasegawa, Noriko, Imanaka, Kazuho, Kawamoto, Seiichi, Inoue, Atsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559959/
https://www.ncbi.nlm.nih.gov/pubmed/28819398
http://dx.doi.org/10.7150/jca.18900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559959/
https://www.ncbi.nlm.nih.gov/pubmed/28819398
http://dx.doi.org/10.7150/jca.18900

Ejemplares similares